Medicure Inc. (OTCMKTS:MCUJF – Get Free Report) was the target of a significant decline in short interest in April. As of April 30th, there was short interest totaling 5,780 shares, a decline of 50.5% from the April 15th total of 11,680 shares. Approximately 0.1% of the company’s stock are sold short. Based on an average daily volume of 182 shares, the days-to-cover ratio is currently 31.8 days.
Medicure Price Performance
Shares of MCUJF stock remained flat at $0.80 during trading on Friday. The stock has a 50-day moving average of $0.83 and a two-hundred day moving average of $0.84. The company has a debt-to-equity ratio of 0.03, a quick ratio of 0.77 and a current ratio of 1.02. The stock has a market capitalization of $8.39 million, a P/E ratio of -1.64 and a beta of 0.97. Medicure has a 1-year low of $0.68 and a 1-year high of $0.97.
Medicure (OTCMKTS:MCUJF – Get Free Report) last announced its quarterly earnings data on Thursday, April 23rd. The company reported ($0.29) EPS for the quarter, missing analysts’ consensus estimates of ($0.04) by ($0.25). The business had revenue of $6.13 million during the quarter, compared to the consensus estimate of $3.62 million. Medicure had a negative return on equity of 41.55% and a negative net margin of 24.61%.
About Medicure
Medicure Pharmaceutical Corp. is a specialty pharmaceutical company focused on the development, manufacturing and commercialization of therapies in the cardiovascular and critical‐care markets. The company advances its business through a combination of in-licensing, acquisitions and strategic partnerships designed to build a diversified portfolio of prescription products that address unmet medical needs.
Headquartered in Montreal, Canada, Medicure operates in North America and selectively in Europe through licensing agreements with regional distributors.
Read More
- Five stocks we like better than Medicure
- Robinhood, SoFi, and Webull Are Telling Very Different Stories
- As Broadcom Eclipses $2 Trillion, Private Credit Giants Wants In
- Target the Red-Hot Spin-Off and Merger Space With These ETFs
- Samsung Joins the $1 Trillion Club as AI Memory Demand Explodes
Receive News & Ratings for Medicure Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medicure and related companies with MarketBeat.com's FREE daily email newsletter.
